logo

AGL

agilon health·NYSE
--
--(--)
--
--(--)
8.52 / 10
Outperform

Fundamental evaluation presents outstanding characteristics (8.5/10). Strengths encompass Net cash flow from operating activities (YoY growth rate %) and Asset-MV, whereas limitations surface in Net income-Revenue and Total profit (YoY growth rate %). This justifies an outstanding view.

Fundamental(8.52)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value3.06
Score2/3
Weight10.39%
1M Return2.84%
Net cash flow from operating activities per share (YoY growth rate %)
Value-14.14
Score1/3
Weight5.59%
1M Return1.22%
Net income-Revenue
Value-0.17
Score0/3
Weight-0.90%
1M Return-0.21%
Basic earnings per share (YoY growth rate %)
Value-28.95
Score3/3
Weight23.02%
1M Return4.75%
Total profit (YoY growth rate %)
Value-50.21
Score0/3
Weight-15.87%
1M Return-4.70%
Net cash flow from operating activities (YoY growth rate %)
Value-14.87
Score2/3
Weight12.84%
1M Return2.70%
Diluted earnings per share (YoY growth rate %)
Value-28.95
Score3/3
Weight24.89%
1M Return5.10%
Asset-MV
Value-0.50
Score3/3
Weight20.74%
1M Return4.29%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-31.16
Score3/3
Weight19.74%
1M Return4.09%
Cash-MV
Value-0.07
Score1/3
Weight-0.45%
1M Return-0.11%
Is AGL fundamentally strong?
  • AGL scores 8.52/10 on fundamentals and holds a Discounted valuation at present. Backed by its -52.11% ROE, -5.24% net margin, -0.85 P/E ratio, 0.88 P/B ratio, and 21.28% earnings growth, these metrics solidify its Outperform investment rating.